Deletion and downregulation of MTAP contribute to the motility of esophageal squamous carcinoma cells

Xiao-Yu Cheng1 State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing;2 Center for Cancer Precision Medicine, Chinese Academy of Medical Sciences < Peking Union Medical College, Beijing, China

Zou Liu1 State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing;2 Center for Cancer Precision Medicine, Chinese Academy of Medical Sciences < Peking Union Medical College, Beijing, China

Li Shang1 State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

Hong-Qing Cai1 State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

Yu Zhang1 State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing;2 Center for Cancer Precision Medicine, Chinese Academy of Medical Sciences < Peking Union Medical College, Beijing, China

Yan Cai1 State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing;2 Center for Cancer Precision Medicine, Chinese Academy of Medical Sciences < Peking Union Medical College, Beijing, China

Xin Xu1 State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing;2 Center for Cancer Precision Medicine, Chinese Academy of Medical Sciences < Peking Union Medical College, Beijing, China

Jia-Jie Hao1 State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing;2 Center for Cancer Precision Medicine, Chinese Academy of Medical Sciences < Peking Union Medical College, Beijing, ChinaCorrespondence[email protected] [email protected]

Ming-Rong Wang1 State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing;2 Center for Cancer Precision Medicine, Chinese Academy of Medical Sciences < Peking Union Medical College, Beijing, ChinaCorrespondence[email protected] [email protected]

show all

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Maroun Bou Zerdan, Prashanth Ashok Kumar, Elio Haroun, Nimisha Srivastava, Jeffrey Ross & Abirami Sivapiragasam. (2023) Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase ( MTAP ) loss . Oncotarget 14:1, pages 178-187.
Crossref

McKaela A. Hodge, Tasha Miller, Marcus A. Weinman, Brandan Wustefeld-Janssens, Shay Bracha & Brian W. Davis. (2023) Cellular Transcriptomics of Carboplatin Resistance in a Metastatic Canine Osteosarcoma Cell Line. Genes 14:3, pages 558.
Crossref

Baiqing Tang, Hyung-Ok Lee, Sapna Gupta, Liqun Wang, Alison M. Kurimchak, James S. Duncan & Warren D. Kruger. (2022) Extracellular 5′-methylthioadenosine inhibits intracellular symmetric dimethylarginine protein methylation of FUSE-binding proteins. Journal of Biological Chemistry 298:9, pages 102367.
Crossref

Bharathi Muruganantham, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, Subramanian Thangaleela & Chaiyavat Chaiyasut. (2022) Bioinformatics Characterization of Candidate Genes Associated with Gene Network and miRNA Regulation in Esophageal Squamous Cell Carcinoma Patients. Applied Sciences 12:3, pages 1083.
Crossref

Wei Liu, Congwen Zhuang, Tengfei Huang, Shengsheng Yang, Meiqing Zhang, Baoquan Lin & Yi Jiang. (2020) Loss of CDKN2A at chromosome 9 has a poor clinical prognosis and promotes lung cancer progression . Molecular Genetics & Genomic Medicine 8:12.
Crossref

Wang Jing, Hui Zhu, Wenjuan Liu, Xiaoyang Zhai, Hairong Tian & Jinming Yu. (2020) MTAP-deficiency could predict better treatment response in advanced lung adenocarcinoma patients initially treated with pemetrexed-platinum chemotherapy and bevacizumab. Scientific Reports 10:1.
Crossref

Robert A. CaseroJrJr, Tracy Murray Stewart & Anthony E. Pegg. (2018) Polyamine metabolism and cancer: treatments, challenges and opportunities. Nature Reviews Cancer 18:11, pages 681-695.
Crossref

Deletion and downregulation of MTAP contribute to the motility of esophageal squamous carcinoma cells

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Deletion and downregulation of MTAP contribute to the motility of esophageal squamous carcinoma cells

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date